Skip to main content
. 2020 Feb 27;2020:5053914. doi: 10.1155/2020/5053914

Table 4.

Top 10 candidate compounds (hemorheological abnormality module and coagulopathy module) according to 2 centrality indexes.

Compounds Degree Compounds Betweenness
Hemorheological abnormality
Quercetin 32 Quercetin 0.0857877
Luteolin 16 Luteolin 0.02594642
Isorhamnetin 13 Butylated hydroxytoluene 0.01562293
Butylated hydroxytoluene 12 Isorhamnetin 0.01488112
Isoliquiritigenin 12 Isoliquiritigenin 0.01377775
Nicotinic acid 12 Gallic acid 0.01187844
Kaempferol 12 Berberine 0.01178984
Rosmarinic acid 11 Nicotinic acid 0.01170317
Campesterol 11 Glycyrrhizic acid 0.01089196
Berberine 10 Rosmarinic acid 0.01077513
Coagulopathy
Quercetin 34 Quercetin 0.0827979
Isorhamnetin 16 Luteolin 0.0211428
Luteolin 14 Wogonin 0.0211385
Kaempferol 14 Isorhamnetin 0.020552
Tangeretin 13 Ellagic acid 0.0161838
Berberine 13 Tanshinone IIB 0.0145945
Columbamine 11 Betaine 0.0142141
Wogonin 11 Berberine 0.0130752
Z-ligustilide 10 Ferulic acid 0.0130271
Ferulic acid 10 Tangeretin 0.0124719

The active compounds which had been verified by UPLC-Q/TOF-MS in QXH were labeled with .